ALDH7A1 and asthma: Theophylline was a mainstay in asthma treatment for over fifty years due to its role as a PDE inhibitor but has fallen out of favor due to its narrow therapeutic index and wide range of gastrointestinal, central nervous system, and cardiovascular side effects.